Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

GMTX

Gemini Therapeutics (GMTX)

Gemini Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GMTX
일자시간출처헤드라인심볼기업
2023/06/3005:18Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2906:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2906:02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2905:23Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2905:13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2905:12Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2205:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2105:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/2105:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1620:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1519:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1305:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1305:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1007:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/1007:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GMTXGemini Therapeutics Inc
2023/06/0921:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/05/1520:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMTXGemini Therapeutics Inc
2023/05/1520:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/04/2020:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GMTXGemini Therapeutics Inc
2023/04/2020:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GMTXGemini Therapeutics Inc
2023/04/2005:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/03/3120:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/03/3120:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/2506:48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1706:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1507:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1506:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1421:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1403:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GMTXGemini Therapeutics Inc
2023/02/1023:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GMTXGemini Therapeutics Inc
 검색 관련기사 보기:NASDAQ:GMTX